Evidence map›Paper›PMID 18826603›Full record

ArticleJournal of medical case reports2008

Diagnostic difficulties of Lactobacillus casei bacteraemia in immunocompetent patients: a case report.

Chiara Tommasi, Francesco Equitani, Marcello Masala, Milva Ballardini, Marco Favaro, Marcello Meledandri, Carla Fontana, Pasquale Narciso, Emanuele Nicastri

Open access · goldAbstract read
In one paragraph

Article in Journal of medical case reports, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. BioMed research international · 2025
    Pooled it
  2. Review
  3. Burrata and the Bean: A Rare Case ofCase reports in infectious diseases · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Evolution of homologous recombination rates across bacteria.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Medical treatment of pouchitis: a guide for the clinician.Therapeutic advances in gastroenterology · 2021
    Review
  13. Article
  14. Probiotic Lactobacilli Precautions.Frontiers in microbiology · 2019
    Article
  15. Article
  16. Open forum infectious diseases · 2017
    Article
  17. Review
  18. Article
  19. Risk and safety of probiotics.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Chiara TommasiNational Institute for Infectious Diseases, INMI 'L, Spallanzani', via portuense, Rome, Italy. ch.tommasi@tiscali.it
Francesco Equitani
Marcello Masala
Milva Ballardini
Marco Favaro
Marcello Meledandri
Carla Fontana
Pasquale Narciso
Emanuele Nicastri
Ospedale San Filippo Neri · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITPoliclinico Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLactobacilli are currently proposed as probiotic agents in several dietary products. In blood cultures, they are usually considered as contaminants, but in recent years they have been recognized as causal infectious agents of endocarditis, urinary tract infections, meningitis, intra-abdominal infections and bacteraemia. CASE PRESENTATION: We report a case of Lactobacillus casei bacteraemia in a 66-year-old immunocompetent man with a history of fever of unknown origin. Leuconostoc bacteraemia was demonstrated by blood culture, but a later polymerase chain reaction analysis with sequencing of 16S ribosomal RNA identified Lactobacillus casei and a successful antibiotic therapy was performed.

conclusionBacteraemia caused by probiotic organisms is rare but underestimated, since they are normally regarded as contaminants and their role as primary invaders is not always easily established. Although the consumption of probiotic products cannot be considered a risk factor in the development of diseases caused by usually non-pathogenic bacteria, specific individual clinical histories should be taken into account. This report should alert both clinicians and microbiologists to the possibility of unusual pathogens causing serious illnesses and to the use of 16S ribosomal RNA sequencing for molecular identification as a powerful tool in confirming the diagnosis of infrequent pathogens.

Identifiers

PMID18826603
PMCPMC2566577
OpenAlexW2110429196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.